178 related articles for article (PubMed ID: 10729771)
1. c-K-ras overexpression is characteristic for metastases derived from a methylcholanthrene-induced fibrosarcoma.
Algarra I; Perez M; Serrano MJ; Garrido F; Gaforio JJ
Invasion Metastasis; 1998-1999; 18(5-6):261-70. PubMed ID: 10729771
[TBL] [Abstract][Full Text] [Related]
2. NK sensitivity, H-2, c-K-ras proto-oncogene expression and metastases: analysis of the metastatic potential of H-2 gene transfected fibrosarcoma cells.
Rager-Zisman B; Gopas J; Bar-Eli M; Har-Vardi I; Hammerling GJ; Segal S
Adv Exp Med Biol; 1988; 233():151-60. PubMed ID: 3066149
[TBL] [Abstract][Full Text] [Related]
3. Association in the expression of Kirsten-ras oncogene and the major histocompatibility complex class I antigens in fibrosarcoma tumor cell variants exhibiting different metastatic capabilities.
Alon Y; Hammerling GJ; Segal S; Bar-Eli M
Cancer Res; 1987 May; 47(10):2553-7. PubMed ID: 3552201
[TBL] [Abstract][Full Text] [Related]
4. A role for the fyn oncogene in metastasis of methylcholanthrene-induced fibrosarcoma A cells.
Takayama T; Mogi Y; Kogawa K; Yoshizaki N; Muramatsu H; Koike K; Semba K; Yamamoto T; Niitsu Y
Int J Cancer; 1993 Jul; 54(5):875-9. PubMed ID: 8325712
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneity of MHC-class-I antigens in clones of methylcholanthrene-induced tumors. Implications for local growth and metastasis.
Algarra I; Gaforio JJ; Garrido A; Mialdea MJ; Pérez M; Garrido F
Int J Cancer Suppl; 1991; 6():73-81. PubMed ID: 2066185
[TBL] [Abstract][Full Text] [Related]
6. Activated c-K-ras and c-N-ras oncogenes in 3-methylcholanthrene-induced BALB/c fibrosarcomas.
Borrello MG; Carbone G; Pierotti MA; Molla A; Della Porta G
Carcinogenesis; 1988 Aug; 9(8):1517-9. PubMed ID: 3402050
[TBL] [Abstract][Full Text] [Related]
7. A weakly tumorigenic phenotype with high MHC class-I expression is associated with high metastatic potential after surgical removal of the primary murine fibrosarcoma.
Pérez M; Algarra I; Ljunggren HG; Caballero A; Mialdea MJ; Gaforio JJ; Klein G; Kärre K; Garrido F
Int J Cancer; 1990 Aug; 46(2):258-61. PubMed ID: 2116997
[TBL] [Abstract][Full Text] [Related]
8. NIH3T3 transfectant containing human K-ras oncogene shows enhanced metastatic activity after in vivo tumor growth or co-culture with fibroblasts.
Takiguchi Y; Takahashi Y; Kuriyama T; Miyamoto T
Clin Exp Metastasis; 1992 Sep; 10(5):351-60. PubMed ID: 1505125
[TBL] [Abstract][Full Text] [Related]
9. Differential mRNA levels of c-myc, c-fos and MHC class I in several clones of a murine fibrosarcoma.
Gaforio JJ; Pérez M; Algarra I; Mialdea MJ; Ljunggren HG; Garrido F
Int J Cancer; 1991 Dec; 49(6):906-10. PubMed ID: 1959995
[TBL] [Abstract][Full Text] [Related]
10. [The relationship between metastatic phenotype and steady expression of BGC-Ha-ras oncogene from metastasis cell lines in nude mice (abstract)].
Li YJ
Zhonghua Zhong Liu Za Zhi; 1992 Nov; 13(6):402-5. PubMed ID: 1349521
[TBL] [Abstract][Full Text] [Related]
11. Effect of MHC class-I transfection on local tumor growth and metastasis in an H-2-negative clone derived from a chemically induced fibrosarcoma.
Mialdea MJ; Martin J; Gaforio JJ; Algarra I; Pérez M; Gonzalez A; Ljunggren HG; Garrido F
Int J Cancer; 1992 Aug; 52(1):153-8. PubMed ID: 1500219
[TBL] [Abstract][Full Text] [Related]
12. Immune response to progressor variants derived from transfection of an ultraviolet radiation-induced C3H mouse regressor tumor cell line with activated Harvey-ras oncogene.
Kaba DS; Pierceall WE; Price JE; Ananthaswamy HN
Cancer Res; 1990 Jun; 50(11):3159-66. PubMed ID: 2185882
[TBL] [Abstract][Full Text] [Related]
13. Protein bound polysaccharide PSK abrogates more efficiently experimental metastases derived from H-2 negative than from H-2 positive fibrosarcoma tumor clones.
Algarra I; Collado A; Garrido F
J Exp Clin Cancer Res; 1997 Dec; 16(4):373-80. PubMed ID: 9505208
[TBL] [Abstract][Full Text] [Related]
14. Activation of ras oncogenes and expression of tumor-specific transplantation antigens in methylcholanthrene-induced murine fibrosarcomas.
Carbone G; Borrello MG; Molla A; Rizzetti MG; Pierotti MA; Della Porta G; Parmiani G
Int J Cancer; 1991 Feb; 47(4):619-25. PubMed ID: 1995490
[TBL] [Abstract][Full Text] [Related]
15. Resistance to NK and metastatic potential of fibrosarcoma cells is associated with products encoded by the H-2D region.
Rager-Zisman B; Aboud M; Gopas J; Har-Vardi I; Hämmerling GJ; Segal S
Semin Cancer Biol; 1991 Oct; 2(5):329-36. PubMed ID: 1773048
[TBL] [Abstract][Full Text] [Related]
16. T24 HRAS transformed NIH/3T3 mouse cells (GhrasT-NIH/3T3) in serial tumorigenic in vitro/in vivo passages give rise to increasingly aggressive tumorigenic cell lines T1-A and T2-A and metastatic cell lines T3-HA and T4-PA.
Ray DB; Merrill GA; Brenner FJ; Lytle LS; Lam T; McElhinney A; Anders J; Rock TT; Lyker JK; Barcus S; Leslie KH; Kramer JM; Rubenstein EM; Pryor Schanz K; Parkhurst AJ; Peck M; Good K; Granath KL; Cifra N; Detweiler JW; Stevens L; Albertson R; Deir R; Stewart E; Wingard K; Richardson MR; Blizard SB; Gillespie LE; Kriley CE; Rzewnicki DI; Jones DH
Exp Cell Res; 2016 Jan; 340(1):1-11. PubMed ID: 26254261
[TBL] [Abstract][Full Text] [Related]
17. NK sensitivity, H-2 expression and metastatic potential: analysis of H-2Dk gene transfected fibrosarcoma cells.
Gopas J; Rager-Zisman B; Har-Vardi I; Hammerling GJ; Bar-Eli M; Segal S
J Immunogenet; 1989; 16(4-5):305-13. PubMed ID: 2639905
[TBL] [Abstract][Full Text] [Related]
18. Characterization of high- and low-metastatic clones derived from a methylcholanthrene-induced murine fibrosarcoma.
Wang N; Yu SH; Liener IE; Hebbel RP; Eaton JW; McKhann CF
Cancer Res; 1982 Mar; 42(3):1046-51. PubMed ID: 6174210
[TBL] [Abstract][Full Text] [Related]
19. Counter-selection for over-expressed human CD44s in primary tumors versus lung metastases in a mouse fibrosarcoma model.
Kogerman P; Sy MS; Culp LA
Oncogene; 1997 Sep; 15(12):1407-16. PubMed ID: 9333016
[TBL] [Abstract][Full Text] [Related]
20. NK sensitivity and lung clearance of MHC-class-I-deficient cells within a heterogeneous fibrosarcoma.
Algarra I; Ohlén C; Perez M; Ljunggren HG; Klein G; Garrido F; Kärre K
Int J Cancer; 1989 Oct; 44(4):675-80. PubMed ID: 2507453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
